Global Imatinib Mesylate Industry share, Growth, Trend and Forecast 20...

This study focuses on the production side and consumption side of Imatinib Mesylate, presents the global Imatinib Mesylate market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

In terms of production side, this report researches the Imatinib Mesylate capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.

In terms of consumption side, this report focuses on the consumption of Imatinib Mesylate by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.

The Imatinib Mesylate market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Imatinib Mesylate.

This report includes the following manufacturers; we can also add the other companies as you want.

GLEEVEC

Cayman Chemical

Sichuan Xieli

Nanjing Kaihua Chemical

Zhengda Tianqing

...

Market Segment by Product Type

99% Purity

98% Purity

Other

Market Segment by Application

CML

GIST

Other

Key Regions split in this report:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

Italy

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

The study objectives are:

To analyze and research the global Imatinib Mesylate status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

To present the key Imatinib Mesylate manufacturers, capacity, production, revenue, market share, and recent development.

To split the breakdown data by regions, type, manufacturers and applications.

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends, drivers, influence factors in global and regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Imatinib Mesylate are as follows:

History Year: 2013-2018

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

Table of Contents

1 Report Overview

1.1 Research Scope

1.2 Major Manufacturers Covered in This Report

1.3 Market Segment by Type

1.3.1 Global Imatinib Mesylate Market Size Growth Rate by Type

1.3.2 99% Purity

1.3.3 98% Purity

1.3.4 Other

1.4 Market Segment by Application

1.4.1 Global Imatinib Mesylate Market Share by Application (2018-2025)

1.4.2 CML

1.4.3 GIST

1.4.4 Other

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Production and Capacity Analysis

2.1.1 Global Imatinib Mesylate Production Value 2013-2025

2.1.2 Global Imatinib Mesylate Production 2013-2025

2.1.3 Global Imatinib Mesylate Capacity 2013-2025

2.1.4 Global Imatinib Mesylate Marketing Pricing and Trends

2.2 Key Producers Growth Rate (CAGR) 2018-2025

2.2.1 Global Imatinib Mesylate Market Size CAGR of Key Regions

2.2.2 Global Imatinib Mesylate Market Share of Key Regions

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

3 Market Share by Manufacturers

3.1 Capacity and Production by Manufacturers

3.1.1 Global Imatinib Mesylate Capacity by Manufacturers

3.1.2 Global Imatinib Mesylate Production by Manufacturers

3.2 Revenue by Manufacturers

3.2.1 Imatinib Mesylate Revenue by Manufacturers (2013-2018)

3.2.2 Imatinib Mesylate Revenue Share by Manufacturers (2013-2018)

3.2.3 Global Imatinib Mesylate Market Concentration Ratio (CR5 and HHI)

3.3 Imatinib Mesylate Price by Manufacturers

3.4 Key Manufacturers Imatinib Mesylate Plants/Factories Distribution and Area Served

3.5 Date of Key Manufacturers Enter into Imatinib Mesylate Market

3.6 Key Manufacturers Imatinib Mesylate Product Offered

3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Production and Production Value for Each Type

4.1.1 99% Purity Production and Production Value (2013-2018)

4.1.2 98% Purity Production and Production Value (2013-2018)

4.1.3 Other Production and Production Value (2013-2018)

4.2 Global Imatinib Mesylate Production Market Share by Type

4.3 Global Imatinib Mesylate Production Value Market Share by Type

4.4 Imatinib Mesylate Ex-factory Price by Type

5 Market Size by Application

5.1 Overview

5.2 Global Imatinib Mesylate Consumption by Application

6 Production by Regions

6.1 Global Imatinib Mesylate Production (History Data) by Regions 2013-2018

6.2 Global Imatinib Mesylate Production Value (History Data) by Regions

6.3 United States

6.3.1 United States Imatinib Mesylate Production Growth Rate 2013-2018

6.3.2 United States Imatinib Mesylate Production Value Growth Rate 2013-2018

6.3.3 Key Players in United States

6.3.4 United States Imatinib Mesylate Import & Export

6.4 Europe

6.4.1 Europe Imatinib Mesylate Production Growth Rate 2013-2018

6.4.2 Europe Imatinib Mesylate Production Value Growth Rate 2013-2018

6.4.3 Key Players in Europe

6.4.4 Europe Imatinib Mesylate Import & Export

6.5 China

6.5.3 Key Players in China

6.5.2 China Imatinib Mesylate Production Value Growth Rate 2013-2018

6.5.3 Key Players in China

6.5.4 China Imatinib Mesylate Import & Export

6.6 Japan

6.6.1 Japan Imatinib Mesylate Production Growth Rate 2013-2018

6.6.2 Japan Imatinib Mesylate Production Value Growth Rate 2013-2018

6.6.3 Key Players in Japan

6.6.4 Japan Imatinib Mesylate Import & Export

6.7 Other Regions

6.7.1 South Korea

6.7.2 India

6.7.3 Southeast Asia

7 Imatinib Mesylate Consumption by Regions

7.1 Global Imatinib Mesylate Consumption (History Data) by Regions

7.2 North America

7.2.1 North America Imatinib Mesylate Consumption by Type

7.2.2 North America Imatinib Mesylate Consumption by Application

7.2.3 North America Imatinib Mesylate Consumption by Countries

7.2.4 United States

7.2.5 Canada

7.2.6 Mexico

7.3 Europe

7.3.1 Europe Imatinib Mesylate Consumption by Type

7.3.2 Europe Imatinib Mesylate Consumption by Application

7.3.3 Europe Imatinib Mesylate Consumption by Countries

7.3.4 Germany

7.3.5 France

7.3.6 UK

7.3.7 Italy

7.3.8 Russia

7.4 Asia Pacific

7.4.1 Asia Pacific Imatinib Mesylate Consumption by Type

7.4.2 Asia Pacific Imatinib Mesylate Consumption by Application

7.4.3 Asia Pacific Imatinib Mesylate Consumption by Countries

7.4.4 China

7.4.5 Japan

7.4.6 Korea

7.4.7 India

7.4.8 Australia

7.4.9 Indonesia

7.4.10 Thailand

7.4.11 Malaysia

7.4.12 Philippines

7.4.13 Vietnam

7.5 Central & South America

7.5.1 Central & South America Imatinib Mesylate Consumption by Type

7.5.2 Central & South America Imatinib Mesylate Consumption by Application

7.5.3 Central & South America Imatinib Mesylate Consumption by Countries

7.5.4 Brazil

7.6 Middle East and Africa

7.6.1 Middle East and Africa Imatinib Mesylate Consumption by Type

7.6.2 Middle East and Africa Imatinib Mesylate Consumption by Application

8 Company Profiles

8.1 GLEEVEC

8.1.1 GLEEVEC Company Details

8.1.2 Company Description and Business Overview

8.1.3 Production and Revenue of Imatinib Mesylate

8.1.4 Imatinib Mesylate Product Introduction

8.1.5 GLEEVEC Recent Development

8.2 Cayman Chemical

8.2.1 Cayman Chemical Company Details

8.2.2 Company Description and Business Overview

8.2.3 Production and Revenue of Imatinib Mesylate

8.2.4 Imatinib Mesylate Product Introduction

8.2.5 Cayman Chemical Recent Development

8.3 Sichuan Xieli

8.3.1 Sichuan Xieli Company Details

8.3.2 Company Description and Business Overview

8.3.3 Production and Revenue of Imatinib Mesylate

8.3.4 Imatinib Mesylate Product Introduction

8.3.5 Sichuan Xieli Recent Development

8.4 Nanjing Kaihua Chemical

8.4.1 Nanjing Kaihua Chemical Company Details

8.4.2 Company Description and Business Overview

8.4.3 Production and Revenue of Imatinib Mesylate

8.4.4 Imatinib Mesylate Product Introduction

8.4.5 Nanjing Kaihua Chemical Recent Development

8.5 Zhengda Tianqing

8.5.1 Zhengda Tianqing Company Details

8.5.2 Company Description and Business Overview

8.5.3 Production and Revenue of Imatinib Mesylate

8.5.4 Imatinib Mesylate Product Introduction

8.5.5 Zhengda Tianqing Recent Development

9 Market Forecast: Production Side

9.1 Production and Production Value Forecast

9.1.1 Global Imatinib Mesylate Capacity, Production Forecast 2018-2025

9.1.2 Global Imatinib Mesylate Production Value Forecast 2018-2025

9.2 Imatinib Mesylate Production and Production Value Forecast by Regions

9.2.1 Global Imatinib Mesylate Production Value Forecast by Regions

9.2.2 Global Imatinib Mesylate Production Forecast by Regions

9.3 Imatinib Mesylate Key Producers Forecast

9.3.1 United States

9.3.2 Europe

9.3.3 China

9.3.4 Japan

9.3.5 Other Regions

9.4 Forecast by Type

9.4.1 Global Imatinib Mesylate Production Forecast by Type

9.4.2 Global Imatinib Mesylate Production Value Forecast by Type

10 Market Forecast: Consumption Side

10.1 Consumption Forecast by Application

10.2 Imatinib Mesylate Consumption Forecast by Regions

10.3 North America Market Consumption Forecast

10.3.1 North America Imatinib Mesylate Consumption Forecast by Countries 2018-2025

10.3.2 United States

10.3.3 Canada

10.3.4 Mexico

10.4 Europe Market Consumption Forecast

10.4.1 Europe Imatinib Mesylate Consumption Forecast by Countries 2018-2025

10.4.2 Germany

10.4.3 France

10.4.4 UK

10.4.5 Italy

10.4.6 Russia

10.5 Asia Pacific Market Consumption Forecast

10.5.1 Asia Pacific Imatinib Mesylate Consumption Forecast by Countries 2018-2025

10.5.2 China

10.5.3 Japan

10.5.4 Korea

10.5.5 India

10.5.6 Australia

10.5.7 Indonesia

10.5.8 Thailand

10.5.9 Malaysia

10.5.10 Philippines

10.5.11 Vietnam

10.6 Central & South America Market Consumption Forecast

10.6.1 Central & South America Imatinib Mesylate Consumption Forecast by Country 2018-2025

10.6.2 Brazil

10.7 Middle East and Africa Market Consumption Forecast

10.7.1 Middle East and Africa Imatinib Mesylate Consumption Forecast by Countries 2018-2025

10.7.2 Middle East and Africa

10.7.3 GCC Countries

10.7.4 Egypt

10.7.5 South Africa

11 Value Chain and Sales Channels Analysis

11.1 Value Chain Analysis

11.2 Sales Channels Analysis

11.2.1 Imatinib Mesylate Sales Channels

11.2.2 Imatinib Mesylate Distributors

11.3 Imatinib Mesylate Customers

12 Opportunities & Challenges, Threat and Affecting Factors

12.1 Market Opportunities

12.2 Market Challenges

12.3 Porter's Five Forces Analysis

12.4 Macroscopic Indicator

12.4.1 GDP for Major Regions

12.4.2 Price of Raw Materials in Dollars: Evolution

13 Key Findings

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

List of Tables and Figures

Figure Imatinib Mesylate Product Picture

Table Imatinib Mesylate Key Market Segments

Table Major Manufacturers Imatinib Mesylate Covered in This Report

Table Global Imatinib Mesylate Market Size Growth Rate by Type 2018-2025 (MT) & (Million US$)

Figure Global Imatinib Mesylate Sales Market Shar by Type 2013-2025

Figure 99% Purity Figures

Table Major Manufacturers of 99% Purity

Figure 98% Purity Figures

Table Major Manufacturers of 98% Purity

Figure Other Figures

Table Major Manufacturers of Other

Table Global Imatinib Mesylate Market Share by Application 2018-2025 (MT)

Figure CML Use Case

Figure GIST Use Case

Figure Other Use Case

Figure Imatinib Mesylate Report Years Considered

Figure Global Imatinib Mesylate Production Value Growth Rate 2013-2025 (Million US$)

Figure Global Imatinib Mesylate Production 2013-2025 (MT)

Figure Global Imatinib Mesylate Capacity 2013-2025 (MT)

Table Key Manufacturers Imatinib Mesylate Capacity (MT)

Figure Global Imatinib Mesylate Price 2013-2025 (USD/MT)

Table Global Imatinib Mesylate Market Size of Key Regions (Million USD) & (MT)

Table Global Imatinib Mesylate Growth Rate of Key Regions 2018-2025 (Million USD)

Table Global Imatinib Mesylate Market Share for of Regions 2018-2025 (MT)

Table Market Top Trends

Table Global Imatinib Mesylate Capacity by Manufacturers (2013-2018) (MT)

Table Global Imatinib Mesylate Capacity Market Share by Manufacturers (2013-2018)

Table Global Imatinib Mesylate Production by Manufacturers (2013-2018) (MT)

Table Global Imatinib Mesylate Production Share by Manufacturers (2013-2018)

Figure Global Imatinib Mesylate Production Share by Manufacturers in 2017

Table Imatinib Mesylate Revenue by Manufacturers (2013-2018) (Million USD)

Table Imatinib Mesylate Revenue Share by Manufacturers (2013-2018)

Figure Imatinib Mesylate Value Share by Manufacturers in 2017

Table Global Imatinib Mesylate Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Imatinib Mesylate Price by Manufacturers 2013-2018 (USD/MT)

Table Key Manufacturers Imatinib Mesylate Plants/Factories Distribution

Table Key Manufacturers Imatinib Mesylate Area Served

Table Date of Key Manufacturers Enter into Imatinib Mesylate Market

Table Key Manufacturers Imatinib Mesylate Product Type

Table Mergers & Acquisitions, Expansion Plans

Table Global 99% Purity Production and Production Value (2013-2018) (MT) & (Million US$)

Table Global 98% Purity Production and Production Value (2013-2018) (MT) & (Million US$)

Table Global Other Production and Production Value (2013-2018) (MT) & (Million US$)

Table Global Imatinib Mesylate Production by Type (2013-2018) (MT)

Table Global Imatinib Mesylate Production Share by Type (2013-2018)

Figure Global Imatinib Mesylate Production Market Share by Type (2013-2018)

Figure Global Imatinib Mesylate Production Market Share by Type in 2017

Table Global Imatinib Mesylate Production Value by Type (2013-2018) (Million US$)

Table Global Imatinib Mesylate Production Value Share by Type (2013-2018)

Figure Global Imatinib Mesylate Production Value Market Share by Type (2013-2018)

Figure Global Imatinib Mesylate Production Value Market Share by Type in 2017

Table Imatinib Mesylate Ex-factory Price by Type 2013-2018 (USD/MT)

Table Global Imatinib Mesylate Consumption by Application (2013-2018) (MT)

Table Global Imatinib Mesylate Consumption Share by Application (2013-2018)

Figure Global Consumption Imatinib Mesylate Market Share by Application (2013-2018)

Table Global Imatinib Mesylate Production by Regions 2013-2018 (MT)

Table Global Imatinib Mesylate Production Market Share by Regions 2013-2018

Figure Global Imatinib Mesylate Production Market Share by Regions 2013-2018

Figure Global Imatinib Mesylate Production Market Share by Regions in 2017

Table Global Imatinib Mesylate Production Value by Regions 2013-2018 (Million USD)

Table Global Imatinib Mesylate Production Value Market Share by Regions 2013-2018

Figure Global Imatinib Mesylate Production Value Market Share by Regions 2013-2018

Figure Global Imatinib Mesylate Production Value Market Share by Regions in 2017

Table United States Imatinib Mesylate Production and Value 2013-2018 (MT) & (Million USD)

Figure United States Imatinib Mesylate Production Growth Rate 2013-2018 (MT)

Figure United States Imatinib Mesylate Production Value Growth Rate 2013-2018 (Million USD)

Table United States Imatinib Mesylate Import & Export (MT)

Table Europe Imatinib Mesylate Production and Value 2013-2018 (MT) & (Million USD)

Figure Europe Imatinib Mesylate Production Growth Rate 2013-2018 (MT)

Figure Europe Imatinib Mesylate Production Value Growth Rate 2013-2018 (Million USD)

Table Europe Imatinib Mesylate Import & Export (MT)

Table China Imatinib Mesylate Production and Value 2013-2018 (MT) & (Million USD)

Figure China Imatinib Mesylate Production Growth Rate 2013-2018 (MT)

Figure China Imatinib Mesylate Production Value Growth Rate 2013-2018 (Million USD)

Table China Imatinib Mesylate Import & Export (MT)

Table Japan Imatinib Mesylate Production and Value 2013-2018 (MT) & (Million USD)

Figure Japan Imatinib Mesylate Production Growth Rate 2013-2018 (MT)

Figure Japan Imatinib Mesylate Production Value Growth Rate 2013-2018 (Million USD)

Table Japan Imatinib Mesylate Import & Export (MT)

Table Global Imatinib Mesylate Consumption by Regions 2013-2018 (MT)

Table Global Imatinib Mesylate Consumption Market Share by Regions 2013-2018

Figure Global Imatinib Mesylate Consumption Market Share by Regions 2013-2018

Figure Global Imatinib Mesylate Consumption Market Share by Regions in 2017

Figure North America Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Table North America Imatinib Mesylate Consumption by Type (2013-2018) (MT)

Figure North America Imatinib Mesylate Consumption Market Share by Type in 2018

Table North America Imatinib Mesylate Consumption by Application (2013-2018) (MT)

Figure North America Imatinib Mesylate Consumption Market Share by Application in 2018

Table North America Imatinib Mesylate Consumption by Countries (2013-2018) (MT)

Figure North America Imatinib Mesylate Consumption Market Share by Countries in 2018

Figure United States Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Canada Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Mexico Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Europe Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Table Europe Imatinib Mesylate Consumption by Type (2013-2018) (MT)

Figure Europe Imatinib Mesylate Consumption Market Share by Type in 2018

Table Europe Imatinib Mesylate Consumption by Application (2013-2018) (MT)

Figure Europe Imatinib Mesylate Consumption Market Share by Application in 2018

Table Europe Imatinib Mesylate Consumption by Countries (2013-2018) (MT)

Figure Europe Imatinib Mesylate Consumption Market Share by Countries in 2018

Figure Germany Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure France Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure UK Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Italy Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Russia Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Asia Pacific Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Table Asia Pacific Imatinib Mesylate Consumption by Type (2013-2018) (MT)

Figure Asia Pacific Imatinib Mesylate Consumption Market Share by Type in 2018

Table Asia Pacific Imatinib Mesylate Consumption by Application (2013-2018) (MT)

Figure Asia Pacific Imatinib Mesylate Consumption Market Share by Application in 2018

Table Asia Pacific Imatinib Mesylate Consumption by Countries (2013-2018) (MT)

Table Asia Pacific Imatinib Mesylate Consumption Market Share by Countries (2013-2018)

Figure China Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Japan Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Korea Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure India Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Australia Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Indonesia Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Thailand Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Malaysia Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Philippines Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Vietnam Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Central & South America Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Table Central & South America Imatinib Mesylate Consumption by Type (2013-2018) (MT)

Figure Central & South America Imatinib Mesylate Consumption Market Share by Type in 2018

Table Central & South America Imatinib Mesylate Consumption by Application (2013-2018) (MT)

Figure Central & South America Imatinib Mesylate Consumption Market Share by Application in 2018

Table Central & South America Imatinib Mesylate Consumption by Countries (2013-2018) (MT)

Figure Central & South America Imatinib Mesylate Consumption Market Share by Countries

Figure Brazil Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Figure Middle East and Africa Imatinib Mesylate Consumption Growth Rate (2013-2018) (MT)

Table Middle East and Africa Imatinib Mesylate Consumption by Type (2013-2018) (MT)

Figure 2017 Middle East and Africa Imatinib Mesylate Consumption Market Share by Type

Table Middle East and Africa Imatinib Mesylate Consumption by Application (2013-2018) (MT)

Figure 2017 Middle East and Africa Imatinib Mesylate Consumption Market Share by Application

Table GLEEVEC Company Details

Table GLEEVEC Description and Business Overview

Table GLEEVEC Imatinib Mesylate Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)

Table GLEEVEC Imatinib Mesylate Production Growth Rate (2013-2018)

Table GLEEVEC Imatinib Mesylate Production Market Share in Global Market

Table GLEEVEC Recent Development

Table Cayman Chemical Company Details

Table Cayman Chemical Description and Business Overview

Table Cayman Chemical Imatinib Mesylate Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)

Table Cayman Chemical Imatinib Mesylate Production Growth Rate (2013-2018)

Table Cayman Chemical Imatinib Mesylate Production Market Share in Global Market

Table Cayman Chemical Recent Development

Table Sichuan Xieli Company Details

Table Sichuan Xieli Description and Business Overview

Table Sichuan Xieli Imatinib Mesylate Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)

Table Sichuan Xieli Imatinib Mesylate Production Growth Rate (2013-2018)

Table Sichuan Xieli Imatinib Mesylate Production Market Share in Global Market

Table Sichuan Xieli Recent Development

Table Nanjing Kaihua Chemical Company Details

Table Nanjing Kaihua Chemical Description and Business Overview

Table Nanjing Kaihua Chemical Imatinib Mesylate Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)

Table Nanjing Kaihua Chemical Imatinib Mesylate Production Growth Rate (2013-2018)

Table Nanjing Kaihua Chemical Imatinib Mesylate Production Market Share in Global Market

Table Nanjing Kaihua Chemical Recent Development

Table Zhengda Tianqing Company Details

Table Zhengda Tianqing Description and Business Overview

Table Zhengda Tianqing Imatinib Mesylate Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)

Table Zhengda Tianqing Imatinib Mesylate Production Growth Rate (2013-2018)

Table Zhengda Tianqing Imatinib Mesylate Production Market Share in Global Market

Table Zhengda Tianqing Recent Development

Table Global Imatinib Mesylate Capacity, Production Forecast 2018-2025 (MT)

Figure Global Imatinib Mesylate Capacity Forecast 2018-2025 (MT)

Figure Global Imatinib Mesylate Production Forecast 2018-2025 (MT)

Figure Global Imatinib Mesylate Production Value Forecast 2018-2025 (Million US$)

Table Global Imatinib Mesylate Revenue Forecast 2018-2025 (Million US$)

Table Global Imatinib Mesylate Production Value Forecast by Regions 2018-2025 (Million US$)

Figure Global Imatinib Mesylate Production Value Forecast by Regions 2018-2025 (Million US$)

Figure Global Imatinib Mesylate Production Value Market Share Forecast by Regions 2018-2025

Table Global Imatinib Mesylate Production Forecast by Regions 2018-2025 (MT)

Figure Global Imatinib Mesylate Production Forecast by Regions 2018-2025 (MT)

Figure Global Imatinib Mesylate Production Market Share Forecast by Regions 2018-2025

Table United States Imatinib Mesylate Production and Value Forecast 2018-2025 (MT) & (Million US$)

Figure United States Imatinib Mesylate Production Forecast 2018-2025 (MT)

Figure United States Imatinib Mesylate Revenue Forecast 2018-2025 (Million US$)

Table Europe Imatinib Mesylate Production and Value Forecast 2018-2025 (MT) & (Million US$)

Figure Europe Imatinib Mesylate Production Forecast 2018-2025 (MT)

Figure Europe Imatinib Mesylate Revenue Forecast 2018-2025 (Million US$)

Table China Imatinib Mesylate Production and Value Forecast 2018-2025 (MT) & (Million US$)

Figure China Imatinib Mesylate Production Forecast 2018-2025 (MT)

Figure China Imatinib Mesylate Revenue Forecast 2018-2025 (Million US$)

Table Japan Imatinib Mesylate Production and Value Forecast 2018-2025 (MT) & (Million US$)

Figure Japan Imatinib Mesylate Production Forecast 2018-2025 (MT)

Figure Japan Imatinib Mesylate Revenue Forecast 2018-2025 (Million US$)

Table Global Imatinib Mesylate Production Forecast by Type 2018-2025 (MT)

Figure Global Imatinib Mesylate Production Forecast by Type 2018-2025 (MT)

Figure Global Imatinib Mesylate Production Market Share Forecast by Type 2018-2025

Table Global Imatinib Mesylate Production Value Forecast by Type 2018-2025 (Million US$)

Figure Global Imatinib Mesylate Production Value Forecast by Type 2018-2025 (Million US$)

Figure Global Imatinib Mesylate Production Value Market Share Forecast by Type 2018-2025

Table Global Imatinib Mesylate Consumption Forecast by Application 2018-2025 (MT)

Figure Global Imatinib Mesylate Consumption Forecast by Application 2018-2025 (MT)

Figure Global Imatinib Mesylate Consumption Market Share Forecast by Application 2018-2025

Table Global Imatinib Mesylate Consumption Forecast by Regions 2018-2025 (MT)

Figure Global Imatinib Mesylate Consumption Forecast by Regions 2018-2025 (MT)

Figure Global Imatinib Mesylate Consumption Market Share Forecast by Regions 2018-2025

Table North America Imatinib Mesylate Consumption Forecast by Regions 2018-2025 (MT)

Figure United States Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure Canada Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure MexicoImatinib Mesylate Consumption Forecast 2018-2025 (MT)

Table Europe Imatinib Mesylate Consumption Forecast by Regions 2018-2025 (MT)

Figure Germany Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure France Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure UK Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure Italy Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure Russia Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Table Asia Pacific Imatinib Mesylate Consumption Forecast by Regions 2018-2025 (MT)

Figure China Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure Japan Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure Korea Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure India Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure Australia Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure Indonesia Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure Thailand Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure Malaysia Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure Philippines Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure Vietnam Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Table Central & South America Imatinib Mesylate Consumption Forecast by Regions 2018-2025 (MT)

Figure Brazil Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Table Middle East and Africa Imatinib Mesylate Consumption Forecast by Regions 2018-2025 (MT)

Figure Middle East and Africa Imatinib Mesylate Consumption Forecast 2018-2025 (MT)

Figure GCC Countries Imatinib Mesylate Sales Growth Rate (2018-2025) (MT)

Figure Egypt Imatinib Mesylate Sales Growth Rate (2018-2025) (MT)

Figure South Africa Imatinib Mesylate Sales Growth Rate (2018-2025) (MT)

Figure Imatinib Mesylate Value Chain

Table Imatinib Mesylate Distributors List

Table Imatinib Mesylate Customers List

Table Porter's Five Forces Analysis

Figure GDP for Major Regions in 2016

Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060

Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016

Figure Saving Rate Total, % of GDP, 2015

Figure Price of raw materials in dollars: Evolution

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

Licenses Type

USD 5,600 Single License

Only one user can access the report

USD 11,200 Enterprise License

Multiple users can access the report

Global Imatinib Mesylate Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

Research Approach

Market Size Estimation

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

Secondary Sources

Primary Sources

Global Isoflurane Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Global Trusses Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Global Poly-Si Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Global Zinc Stearates Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Global HDPE Pipe for Gas Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Licenses Type

Why QYR

Fastest report delivery service

More than 10 years of vast experience

Operational for **24 * 7 & 365 days**

In-depth and comprehensive analysis

Excellent after sales support

Owns large database

Need Help ?